Thermo Fisher Scientific (TMO) reported an earnings beat for its 3rd quarter, ending 9/30/2022. Earnings per share got here in at $5.08, versus the anticipated $4.81.
The reported income of $10.68 billion represents a lower of -2.67% in comparison with the earlier quarter, and development of 14.44% in comparison with the identical interval final 12 months.
For the 4th quarter, analysts undertaking earnings of $5.31 per share.
Typically, earnings bulletins have an effect on a inventory’s value. See a historical past of earnings-related value modifications for TMO inventory.
What’s subsequent for Thermo Fisher Scientific publish earnings
In response to TipRanks, the typical analyst consensus on TMO inventory is a Sturdy Purchase. This consensus is predicated on 10 analyst scores made prior to now 3 months. Thermo Fisher Scientific’s common value goal of $658.78 implies upside potential of 30.97% from present ranges.
See our Earnings Calendar for a full listing of this week’s earnings releases.
Backside Line
An earnings beat can signify optimistic motion forward for a inventory’s value. At present, TMO value is $503.00, indicating a 5-day rise of 1.26%.
About Thermo Fisher Scientific
Thermo Fisher Scientific, Inc. gives analytical devices, tools, reagents and consumables, software program and companies for analysis, evaluation, discovery, and diagnostics. It operates by means of the Life Sciences Options, Analytical Devices, Specialty Diagnostics, and Laboratory Merchandise and Companies segments. The corporate was based on October 11, 1960 and is headquartered in Waltham, MA..
Be taught extra about TMO financials right here
